Web Reference: Michael Chambers is a scientific advisor at RoslinCT, a biotechnology company. He also co-founded Aldevron, a leading supplier to the genomic medicine sector, and invested in several other technology companies. Michael Chambers is the founding CEO of Aldevron, a company that specializes in nucleic acid, protein, and enzyme production and that has developed novel quality systems and technologies to accelerate the genetic medicine sector. Dec 12, 2022 · Michael Chambers, the founding CEO of Aldevron, a biotech company that makes custom DNA and proteins, has been elected to the board of directors for the Whitehead Institute at MIT. The Whitehead Institute is a nonprofit biomedical research center that solves "deep scientific mysteries underlying many diseases".
YouTube Excerpt: The new boardroom and dedicated training space are named after Founders
Information Profile Overview
Michael Chambers Aldevron - Latest Information & Updates 2026 Information & Biography
Details: $17M - $28M
Salary & Income Sources
Career Highlights & Achievements
Assets, Properties & Investments
This section covers known assets, real estate holdings, luxury vehicles, and investment portfolios. Data is compiled from public records, financial disclosures, and verified media reports.
Last Updated: April 8, 2026
Information Outlook & Future Earnings
Disclaimer: Disclaimer: Information provided here is based on publicly available data, media reports, and online sources. Actual details may vary.